Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9 CAD | +1.35% | -0.66% | +20.64% |
Mar. 14 | Transcript : Sylogist Ltd., Q4 2023 Earnings Call, Mar 14, 2024 | |
Mar. 14 | Sylogist Brief: Q4 Total revenue of $16.2 million, up 5.4% Y/Y | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 234.2 | 279.8 | 308.3 | 147.3 | 175.9 | 211.2 | - | - |
Enterprise Value (EV) 1 | 181.1 | 237.5 | 297.7 | 132.8 | 175.9 | 210.1 | 201.2 | 169 |
P/E ratio | - | - | 71.6 x | 56 x | 149 x | 51.9 x | 31.4 x | 18 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 6.23 x | 7.35 x | 7.97 x | 2.14 x | 2.68 x | 2.92 x | 2.59 x | 2.26 x |
EV / Revenue | 4.82 x | 6.24 x | 7.7 x | 1.92 x | 2.68 x | 2.9 x | 2.47 x | 1.8 x |
EV / EBITDA | 10.3 x | 11.4 x | 16.2 x | 7.71 x | 10.2 x | 11.1 x | 8.53 x | 5.85 x |
EV / FCF | 10.7 x | 93.9 x | 16.6 x | - | - | 18.6 x | 11.3 x | 7.24 x |
FCF Yield | 9.3% | 1.07% | 6.04% | - | - | 5.37% | 8.85% | 13.8% |
Price to Book | - | - | 6.6 x | - | - | - | - | - |
Nbr of stocks (in thousands) | 23,777 | 23,716 | 23,916 | 23,916 | 23,574 | 23,466 | - | - |
Reference price 2 | 9.850 | 11.80 | 12.89 | 6.160 | 7.460 | 9.000 | 9.000 | 9.000 |
Announcement Date | 1/16/20 | 12/17/20 | 12/13/21 | 3/23/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 37.61 | 38.08 | 38.68 | 69 | 65.51 | 72.36 | 81.52 | 93.64 |
EBITDA 1 | 17.6 | 20.79 | 18.42 | 17.21 | 17.3 | 18.91 | 23.6 | 28.89 |
EBIT 1 | - | - | 11.75 | 4.935 | 3.487 | 6.906 | 10.04 | - |
Operating Margin | - | - | 30.39% | 7.15% | 5.32% | 9.54% | 12.31% | - |
Earnings before Tax (EBT) 1 | - | - | - | - | 1.544 | 5.146 | 8.278 | - |
Net income 1 | - | - | 4.373 | 2.541 | 1.1 | 3.808 | 6.126 | - |
Net margin | - | - | 11.31% | 3.68% | 1.68% | 5.26% | 7.51% | - |
EPS 2 | - | - | 0.1800 | 0.1100 | 0.0500 | 0.1733 | 0.2867 | 0.5000 |
Free Cash Flow 1 | 16.85 | 2.53 | 17.99 | - | - | 11.29 | 17.8 | 23.36 |
FCF margin | 44.79% | 6.64% | 46.51% | - | - | 15.6% | 21.83% | 24.94% |
FCF Conversion (EBITDA) | 95.73% | 12.17% | 97.63% | - | - | 59.69% | 75.44% | 80.86% |
FCF Conversion (Net income) | - | - | 411.32% | - | - | 296.45% | 290.56% | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 1/16/20 | 12/17/20 | 12/13/21 | 3/23/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 9.519 | 10.8 | 15.34 | 15.92 | 16.65 | 16.77 | 16.17 | 16.78 | 17.98 | 18.82 | 18.71 | 19.6 |
EBITDA 1 | 3.001 | 5.032 | 4.878 | 3.842 | 4.3 | 4.372 | 4.8 | 4.135 | 4.617 | 5.108 | 5.014 | 5.6 |
EBIT 1 | - | 2.89 | 0.366 | 1.303 | - | - | 0.94 | 1.333 | 1.046 | 2.356 | 2.171 | - |
Operating Margin | - | 26.76% | 2.39% | 8.18% | - | - | 5.81% | 7.94% | 5.82% | 12.52% | 11.6% | - |
Earnings before Tax (EBT) 1 | - | - | - | - | 0.014 | 0.79 | 0.483 | 0.893 | 0.606 | 1.916 | 1.731 | - |
Net income 1 | - | 1.387 | -0.33 | 0.103 | -0.072 | 0.845 | 0.224 | 0.661 | 0.449 | 1.418 | 1.281 | - |
Net margin | - | 12.84% | -2.15% | 0.65% | -0.43% | 5.04% | 1.39% | 3.94% | 2.5% | 7.54% | 6.85% | - |
EPS 2 | - | 0.0500 | -0.0100 | 0.004000 | - | 0.0400 | 0.0100 | 0.0333 | 0.0367 | 0.0533 | 0.0500 | 0.0500 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 8/12/21 | 12/13/21 | 3/23/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/14/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | 53.1 | 42.3 | 10.6 | 14.5 | - | 1.07 | 9.99 | 42.2 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 16.8 | 2.53 | 18 | - | - | 11.3 | 17.8 | 23.4 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | 1.950 | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | 0.09 | - | - | 0.1 | 0.1 | 5.7 |
Capex / Sales | - | - | 0.23% | - | - | 0.14% | 0.12% | 6.09% |
Announcement Date | 1/16/20 | 12/17/20 | 12/13/21 | 3/23/23 | 3/14/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.64% | 154M | |
+8.05% | 3,020B | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
+31.16% | 50.15B | |
-24.56% | 46.71B | |
+17.75% | 41.41B | |
+55.21% | 36.1B | |
-10.24% | 24.64B |
- Stock Market
- Equities
- SYZ Stock
- Financials Sylogist Ltd.